Table 2.
Parameter | Unit | Study group (n = 56) | Reference group (n = 24) | P-value |
---|---|---|---|---|
Median (range) | Median (range) | |||
CHOL | mg/dL | 231 | 194.5 | 0.029 |
(162–363) | (101–282) | |||
LDL | mg/dL | 160.5 | 117.4 | < 0.001 |
(88–314) | (55.7–192) | |||
TG | mg/dL | 139.3 | 127.5 | 0.921 |
(40–411) | (45–211) | |||
HDL | mg/dL | 50.47 | 59.21 | 0.043 |
(31–90) | (37–114) | |||
GLUCOSE | mg/dL | 96.05 | 96.44 | 0.508 |
(77–154) | (69–248) | |||
CRP | mg/L | 2.15 | 3.4 | 0.587 |
(0.4–8.8) | (0.2–32.6) | |||
25-OH VIT D | ng/ml | 27.28 | 27.19 | 0.597 |
(10.6–51.1) | (8.2–82.6) | |||
TGB | ng/ml | 4.4 | 1.3 | 0.054 |
(0.04–37.05) | (0.04–3.2) | |||
TGBAb | IU/mL | 11.22 | 8.99 | 0.713 |
(0.6–132.4) | (0–185) | |||
TSH | μIU/mL | 0.76 | 4.38 | 0.092 |
(0.05–3.83) | (0.09–7.3) | |||
FT3 | pg/mL | 2.64 | 2.64 | 0.883 |
(1.36–3.76) | (1.0–6.27) | |||
FT4 | ng/dL | 1.2 | 1.18 | 0.941 |
(0.54–2.14) | (0.4–1.82) |
Bold indicates that the values given are statistically significant.
CHOL, cholesterol; CRP, C-reactive protein; PTC, papillary thyroid cancer; fT3, free triiodothyronine; fT4, free thyroxine; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; TGB, thyroglobulin; TGBAb, antithyroglobulin antibodies; TSH, thyroid-stimulating hormone; VIT D, vitamin D.